Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Harter

Showing results (61-70 of 276) with videos related to

Pageof 28
Sort By:
Gynecologic Oncology|March 19, 2011
Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancerPhilipp Harter, Zelal M Muallem, Christine Buhrmann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2009
Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR GermanyJacobus Pfisterer, Andreas Du Bois, Eva-Katrin Bentz, et al.
Archives of Gynecology and Obstetrics|May 21, 2015
Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancerChristina Fotopoulou, Ahmed El-Balat, Andreas du Bois, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2010
Abdominal wall metastases in patients with ovarian cancer after laparoscopic surgery: incidence, risk factors, and complicationsFlorian Heitz, Dejan Ognjenovic, Philipp Harter, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2015
Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: a systematic review and meta-analysis of clinical trials in advanced cancer patientsThomas Powles, Sergio Bracarda, Mei Chen, et al.
Annals of Surgical Oncology|April 11, 2018
Stage- and Histologic Subtype-Dependent Frequency of Lymph Node Metastases in Patients with Epithelial Ovarian Cancer Undergoing Systematic Pelvic and Paraaortic LymphadenectomyFlorian Heitz, Philipp Harter, Beyhan Ataseven, et al.
Gynecologic Oncology|January 28, 2014
Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancerPhilipp Harter, Bianca Beutel, Piero F Alesina, et al.
Onkologie|September 21, 2013
Outcome of early breast cancer treated in an urban and a rural breast cancer unit in GermanyFlorian Heitz, Alexandra Bender, Jana Barinoff, et al.
Oncology|April 26, 2013
Differences in the receptor status between primary and recurrent breast cancer--the frequency of and the reasons for discordanceFlorian Heitz, Jana Barinoff, Ondra du Bois, et al.
Current Oncology Reports|January 29, 2020
Low-grade Serous Tumors: Are We Making Progress?Nina Pauly, Sarah Ehmann, Enzo Ricciardi, et al.
Pageof 28

Showing results (61-70 of 276) with videos related to

Sort By:
Pageof 28
Gynecologic Oncology|March 19, 2011
Impact of a structured quality management program on surgical outcome in primary advanced ovarian cancerPhilipp Harter, Zelal M Muallem, Christine Buhrmann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 5, 2009
Prognostic value of human epidermal growth factor receptor 2 (Her-2)/neu in patients with advanced ovarian cancer treated with platinum/paclitaxel as first-line chemotherapy: a retrospective evaluation of the AGO-OVAR 3 Trial by the AGO OVAR GermanyJacobus Pfisterer, Andreas Du Bois, Eva-Katrin Bentz, et al.
Archives of Gynecology and Obstetrics|May 21, 2015
Systematic pelvic and paraaortic lymphadenectomy in early high-risk or advanced endometrial cancerChristina Fotopoulou, Ahmed El-Balat, Andreas du Bois, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 9, 2010
Abdominal wall metastases in patients with ovarian cancer after laparoscopic surgery: incidence, risk factors, and complicationsFlorian Heitz, Dejan Ognjenovic, Philipp Harter, et al.
European Journal of Cancer (Oxford, England : 1990)|April 23, 2015
Characterisation of liver chemistry abnormalities associated with pazopanib monotherapy: a systematic review and meta-analysis of clinical trials in advanced cancer patientsThomas Powles, Sergio Bracarda, Mei Chen, et al.
Annals of Surgical Oncology|April 11, 2018
Stage- and Histologic Subtype-Dependent Frequency of Lymph Node Metastases in Patients with Epithelial Ovarian Cancer Undergoing Systematic Pelvic and Paraaortic LymphadenectomyFlorian Heitz, Philipp Harter, Beyhan Ataseven, et al.
Gynecologic Oncology|January 28, 2014
Prognostic and predictive value of the Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) score in surgery for recurrent ovarian cancerPhilipp Harter, Bianca Beutel, Piero F Alesina, et al.
Onkologie|September 21, 2013
Outcome of early breast cancer treated in an urban and a rural breast cancer unit in GermanyFlorian Heitz, Alexandra Bender, Jana Barinoff, et al.
Oncology|April 26, 2013
Differences in the receptor status between primary and recurrent breast cancer--the frequency of and the reasons for discordanceFlorian Heitz, Jana Barinoff, Ondra du Bois, et al.
Current Oncology Reports|January 29, 2020
Low-grade Serous Tumors: Are We Making Progress?Nina Pauly, Sarah Ehmann, Enzo Ricciardi, et al.
Pageof 28